Cannabis - Aspectos regulatorios
Situación en diversos países
Portugal
Fuente: PubMed [Internet]. Bethesda (MD): US National Library of Medicine National Institutes of Health; [consulta 25 may 2022]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/
Detalles de búsqueda: (("cannabis"[MeSH Terms] OR "cannabis"[All Fields] OR "cannabi"[All Fields] OR "cannabis s"[All Fields]) AND ("legislation"[Publication Type] OR "legislation as topic"[MeSH Terms] OR "legislation"[All Fields]) AND ("portugal"[MeSH Terms] OR "portugal"[All Fields] OR "portugal"[All Fields])) AND (y_5[Filter])
2022
2021
- López-Pelayo H, Matrai S, Balcells-Olivero M, Campeny E, Braddick F, Bossong MG, et al. Standard units for cannabis dose: Why is it important to standardize cannabis dose for drug policy and how can we enhance its place on the public health agenda? Int J Drug Policy. noviembre de 2021;97:103350.
- Barata PC, Ferreira F, Oliveira C. Cannabis Non-medical Use: International Policies and Outcomes Overview. An Outline for Portugal. Trends Psychiatry Psychother. 23 de septiembre de 2021;
- López-Pelayo H, Matrai S, Balcells-Olivero M, Campeny E, Braddick F, Bossong MG, et al. Supporting Future Cannabis Policy - Developing a Standard Joint Unit: A Brief Back-Casting Exercise. Front Psychiatry. 2021;12:675033.
2019
- Gonçalves J, Rosado T, Soares S, Simão AY, Caramelo D, Luís Â, et al. Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination. Medicines (Basel). 23 de febrero de 2019;6(1).
- Maia J, Midão L, Cunha SC, Almada M, Fonseca BM, Braga J, et al. Effects of cannabis tetrahydrocannabinol on endocannabinoid homeostasis in human placenta. Arch Toxicol. marzo de 2019;93(3):649-58.
2018
2017
